GENA THOMPSON: Open Payments
NPI 1629668900 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 30 payments from 12 companies in 2025. Trend: 2023 $492 · 2024 $512 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $154 |
| PFIZER INC. | 5 | $97 |
| Corcept Therapeutics | 3 | $66 |
| Lilly USA, LLC | 3 | $53 |
| Smith+Nephew, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: ELIQUIS, QULIPTA, Korlym, MOUNJARO, LINZESS, VRAYLAR, NURTEC ODT, COLLAGENASE SANTYL.
Industry payments across MS — which companies pay providers there.
